WallStreetZenWallStreetZen

NYSEMKT: CHRO
Chromocell Therapeutics Corp Stock Ownership - Who owns Chromocell Therapeutics?

OverviewEarningsDividendOwnership

Insider buying vs selling

Have Chromocell Therapeutics Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Todd C. DavisDirector2024-02-2129,167$4.80
$140.00kBuy
Ezra M. FriedbergDirector2024-02-216,992$4.80
$33.56kBuy
Ezra M. FriedbergDirector2024-02-2113,649$4.80
$65.52kBuy
Ezra M. FriedbergDirector2024-02-2116,667$6.00
$100.00kBuy

1 of 1

CHRO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRO insiders and whales buy or sell their stock.

CHRO Shareholders

What type of owners hold Chromocell Therapeutics Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ezra M. Friedberg18.14%1,066,440$1.71MInsider
Motif Pharmaceuticals Ltd8.01%470,674$753.08kInsider
Boswell Prayer Ltd7.82%459,895$735.83kInsider
Aperture Healthcare Ventures Ltd7.26%426,566$682.51kInsider
Ame Equities LLC5.97%351,163$561.86kInsider
Todd C. Davis0.50%29,167$46.67kInsider

1 of 1

CHRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRO0.00%47.70%Net BuyingNet Buying
AEZS0.73%0.00%
MTEM1.90%98.10%Net BuyingNet Buying
ERNA0.91%99.09%Net Selling
CMMB0.99%5.96%
View Top Biotech Stocks

Chromocell Therapeutics Stock Ownership FAQ

Who owns Chromocell Therapeutics?

Chromocell Therapeutics (NYSEMKT: CHRO) is owned by 0.00% institutional shareholders, 47.70% Chromocell Therapeutics insiders, and 52.30% retail investors. Ezra M. Friedberg is the largest individual Chromocell Therapeutics shareholder, owning 1.07M shares representing 18.14% of the company. Ezra M. Friedberg's Chromocell Therapeutics shares are currently valued at $1.71M.

If you're new to stock investing, here's how to buy Chromocell Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.